Sciarra

Pharma

Pipeline Programs↗

Distinct drugs in development (Preclinical–Phase 3)

Indications↗

Distinct diseases across all programs

Clinical Trials↗

All sponsored trials (all statuses)

Activity

Key Events

Details

Company Overview

—

Mkt Cap

—

Revenue

—

Cash

Regulatory

19971 event

FDADec 24

Sclerosol — SCLEROSOL

Application NDA020587 (NDA)

20031 event

FDADec 15

Sclerosol — TALC

Application NDA021388 (NDA)

20171 event

FDAMay 1

Sclerosol — STERITALC

Application NDA205555 (NDA)

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)